Kajiyama and colleagues (Nutrition Research, 2008) — one of the earliest human studies: 36 people with type 2 diabetes or impaired glucose tolerance, randomized, double-blind, placebo-controlled, eight weeks of HRW.\n\nImprovements were described in the lipid profile and oxidation markers; the HOMA index showed upward tendencies in subgroups. The authors deliberately spoke cautiously of a possible preventive role.\n\nSince then, further studies and analyses on glucose and lipid markers have appeared. The overall picture remains heterogeneous: small samples, different H₂ concentrations, varying durations.\n\nImportant: for people with diabetes, HRW changes nothing about medication, glucose self-monitoring or medical care. It is a research topic — not a therapy and not a substitute for treatment.
Key claims and evidence
A small RCT (n=36) described improved lipid and oxidation markers in type 2 diabetes with HRW.
Medical notice (HWG)
This content is for information only and does not replace medical advice, diagnosis or treatment. Effect statements are phrased cautiously and rely on the cited studies; human studies are partly small and preliminary. Food supplements are not a substitute for a balanced diet. Please consult a doctor for health concerns.